Dr. Catalona’s National Media Coverage

In the past, even patients with low-risk prostate cancer would often be treated with surgery or radiotherapy, despite potentially serious side effects from the treatment. Recent years have seen a

Gleason 3+3=6 is the lowest grade cancer in the traditional Gleason scoring system. Now, some urologists see a Gleason 6 as a noncancerous growth that has the potential to be

At the 2020 American Urological Association (AUA) conference, Dr. Catalona participated in a plenary session at the conference entitled Crossfire: Controversies in Urology: Prostate Cancer Active Surveillance Can be Done

Dutch and American investigators published a modeling study that concluded lengthening the interval between prostate cancer screenings beyond two years for men with low PSA levels would reduce testing burden

Chicago magazine named Dr. Catalona as a 2020 Top Doctor in Urology. The physicians on the list were chosen by their peers as the finest in the Chicago area.

In 2001, Syracuse University basketball coach Jim Boeheim was diagnosed with prostate cancer at age 56. Shortly after his diagnosis, Dr. Catalona performed Boeheim’s radical prostatectomy. Boeheim spoke to The

Visual registration, in which multiparametric MRI targets are translated onto real-time ultrasound images, combined with image fusion software may offer the highest detection rate of clinically significantly prostate cancer and

Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, reports a 20-year study from Northwestern Medicine published in the journal European

Moving from bench to bedside in just five years may sound like a daunting task, but the Lurie Cancer Center’s Prostate Cancer SPORE is on track to produce tangible benefits

A new European genomic study found that the prostate-specific ANO7 gene may play a critical role in the development of aggressive prostate cancer. The researchers found that tumors with certain